| Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Schizophrenia;Bipolar Disorder, Date of authorisation: 30/06/2015, Revision: 12, Status: Authorised | | Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Schizophrenia;Bipolar Disorder, Date of authorisation: 30/06/2015, Revision: 12, Status: Authorised |
|
| Human medicines European public assessment report (EPAR): Integrilin, eptifibatide, Angina, Unstable;Myocardial Infarction, Date of authorisation: 01/07/1999, Revision: 26, Status: Authorised | | Human medicines European public assessment report (EPAR): Integrilin, eptifibatide, Angina, Unstable;Myocardial Infarction, Date of authorisation: 01/07/1999, Revision: 26, Status: Authorised |
|
|